Journals / New Trends in Medicine Sciences / 2022 / Cilt: 3 - Sayı: 1

Acinetobacteria Baumanni Infection in the Intensive Care Unit–Risk Factors and Antibiotic Resistance

Pages
55–60
Publication Date
2022-01-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Increased carbapenem resistance is currently trending and this causes longer duration of hospital stay and increased mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:BACKGROUND: The rate of hospital infections are 5 – 10 times higher in he intensive care unit compared to inpatient clinics.MATERIALS & METHOD: The bacterial cultural analysis have been conducted to all patients and 70 subjects that were positive for acinetobacter baumanniicolonisation have been included in the analysis.
📊
Key Findings & Data:The data on age, gender, smoking, comorbidities, steroid usage and antibiotic treatment within the first 24 hours has been recorded in the analysis.
💡
Conclusion & Impact:Increased carbapenem resistance is currently trending and this causes longer duration of hospital stay and increased mortality.
🔬Design:Research Article
📍Scope:84 samples
⚙️Variables:A. baumannii · antibiotics resistance · intensive care unit

Abstract

BACKGROUND: The rate of hospital infections are 5 – 10 times higher in he intensive care unit compared to inpatient clinics.MATERIALS & METHOD: The bacterial cultural analysis have been conducted to all patients and 70 subjects that were positive for acinetobacter baumanniicolonisation have been included in the analysis. The data on age, gender, smoking, comorbidities, steroid usage and antibiotic treatment within the first 24 hours has been recorded in the analysis. Septic shock patients who did not respond to intense fluid replacement and needed dopamine infusion for the treatment of hypotension were also interpreted. The results of antibiogram culture, duration of non-invasive and invazive mechanical ventilation, hospital stay and mortality information have all been investigated for the analyis. The APACHE and SOFA scores of the first admission day have been calculated. RESULTS: Invasive mechanical ventilation has been conducted to 66 patients and the median duration of administration was 19.5±23.94 (1-138, range: 138) days. The APACHE II score was 24.69±8.37 and SOFA score was 10.43±3.42. The mean hospital stay was 26.03±24.23 (1-139, range 138) days. The mean time of observing positive culture from hospital admission was 15.55±1.19 days. The distribution of 84 samples were as follows: n=40 (47.6) from blood, n=26 (31%) deep tracheal aspiration material, n=7 (8.3%) from urine, n=7 (8.3%) from wound, n=4 (4.8%) from catheter. CONCLUSION: The antimicrobial regimen must be reassigned according to bacterial culture results. Increased carbapenem resistance is currently trending and this causes longer duration of hospital stay and increased mortality.

🔖

Cite This Article

ÇİL, B., KÜTÜK, E., KABAK, M., HOCANLI, İ., YILDIZ, T. (2022). Acinetobacteria Baumanni Infection in the Intensive Care Unit–Risk Factors and Antibiotic Resistance. New Trends in Medicine Sciences, Cilt: 3 - Sayı: 1, 55–60. https://ajindex.com/articles/792450

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Wong D, Nielsen TB, Bonomo R A, Pantapalangkoor P, Luna B, and Spellberg B. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol. 2017;30:409–447
  2. Neidell MJ, Cohen B, Furuya Y, Hill J, Jeon CY, Glied S, Larson EL. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clin Infect Dis. 2012 Sep;55(6):807-15
  3. Tüfek A, Tekin R, Dal T, Tokgöz O, Doğan E, Kavak G, Hoşoğlu S. Evaluation of hospital infections developing in intensive care unit during a decade and review of literature.Dicle Medical Journal. 2012;39:492-498
  4. Martín-Aspas A, Guerrero-Sánchez FM, García-Colchero F, Rodríguez-Roca S, Girón-González JA. Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality. Inf. Drug Resist. 2018;11: 861–872
  5. Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat. Rev. Microbiol. 2018; 16:91–102
  6. Lob SH, Hoban DJ, Sahm DF, Badal RE. Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii. Int. J. Antimicrob. Agents 2016;47:317–323
  7. WHO. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. Available online: https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/ (accessed on 20 April 2020)
  8. Kim YJ, Kim S, Hong KW, Kim YR, Park YJ, Kang MW. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: Impact of appropriate antimicrobial therapy. J. Korean Med. Sci. 2012; 27: 471–475
  9. Ayobami O, Willrich N, Harder T, Okeke IN, Eckmanns T, Markwart R. The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis. Emerg Microbes Infect. 2019;8(1):1747-1759
  10. Leão A C, Menezes PR, Oliveira MS, Levin AS. Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis. BMC Infect. Dis. 2016; 16:386
  11. Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. J. Hosp. Infect. 2009;73:143–150
  12. Lahmer T, Messer M,